-- 
Medivir Names BioPhausia’s Hartmanis as CEO, Replacing Long

-- B y   P h i l   S e r a f i n o
-- 
2011-09-26T06:41:22Z

-- http://www.bloomberg.com/news/2011-09-26/medivir-names-biophausia-s-hartmanis-as-ceo-replacing-long.html
Medivir AB (MVIRB)  named Maris Hartmanis as
chief executive officer, replacing Ron Long, who also stepped
down from the board. Hartmanis was appointed CEO of the
specialty pharmaceutical company BioPhausia in 2010, and was
named deputy CEO and COO of Medivir after Medivir’s acquisition
of BioPhausia this year.  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  